These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4282845)

  • 21. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
    Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR
    J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heparin sulfate fractions on coagulation and hemostasis.
    Nader HB; Dietrich CP
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):504-8. PubMed ID: 4275736
    [No Abstract]   [Full Text] [Related]  

  • 23. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA; Petäjä J; Griffin JH
    Thromb Haemost; 1999 Nov; 82(5):1462-8. PubMed ID: 10595639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin and heparan sulfate partially inhibit induction of acetylcholine receptor accumulation by nerve in Xenopus culture.
    Hirano Y; Kidokoro Y
    J Neurosci; 1989 May; 9(5):1555-61. PubMed ID: 2524554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo release of anti-Xa clotting activity by a heparin analogue.
    Thomas DP; Barrowcliffe TW; Merton RE; Stocks J; Dawes J; Pepper DS
    Thromb Res; 1980 Mar; 17(6):831-40. PubMed ID: 6773178
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of glycosaminoglycans on the growth of cultured tumor cells.
    Nagasawa S
    J Osaka Dent Univ; 1993 Oct; 27(2):121-33. PubMed ID: 8182504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
    Matzner Y; Marx G; Drexler R; Eldor A
    Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells.
    Marsh NA; Minter AJ; Chesterman CN
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):133-8. PubMed ID: 1966669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release of diamine oxidase into plasma by glycosaminoglycans in rats.
    D'Agostino L; Pignata S; Daniele B; Ventriglia R; Ferrari G; Ferraro C; Spagnuolo S; Lucchelli PE; Mazzacca G
    Biochim Biophys Acta; 1989 Dec; 993(2-3):228-32. PubMed ID: 2512987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest.
    Godal HC; Gjengedal G
    Scand J Haematol; 1971; 8(3):194-9. PubMed ID: 5093996
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
    Nurmohamed MT; Fareed J; Hoppensteadt D; Walenga JM; ten Cate JW
    Semin Thromb Hemost; 1991; 17 Suppl 2():205-13. PubMed ID: 1948091
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
    Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiangiogenic effect of heparin and other sulphated glycosaminoglycans in the chick embryo chorioallantoic membrane.
    Jakobson AM; Hahnenberger R
    Pharmacol Toxicol; 1991 Aug; 69(2):122-6. PubMed ID: 1723204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.
    Karnovsky MJ; Wright TC; Castellot JJ; Choay J; Lormeau JC; Petitou M
    Ann N Y Acad Sci; 1989; 556():268-81. PubMed ID: 2525359
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin and related glycosaminoglycans modulate the secretory phenotype of vascular smooth muscle cells.
    Majack RA; Bornstein P
    J Cell Biol; 1984 Nov; 99(5):1688-95. PubMed ID: 6490716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of macrophage and B cell function by glycosaminoglycans.
    Wrenshall LE; Stevens RB; Cerra FB; Platt JL
    J Leukoc Biol; 1999 Sep; 66(3):391-400. PubMed ID: 10496308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of glycosaminoglycans on endogenous DNA synthesis in isolated normal and cancer cell nuclei. Differential effect of heparin.
    Furukawa K; Bhavanandan VP
    Biochim Biophys Acta; 1982 Jun; 697(3):344-52. PubMed ID: 6809052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Physico-chemical characteristics of heparin in relation to its anticoagulant and anti-hemostatic action].
    Nader HB; Dietrich CP; Straus AH; Takahashi HK
    Rev Bras Biol; 1979 Nov; 39(4):793-816. PubMed ID: 162073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.